Clinical laboratories historically diagnose seven or eight respiratory virus infections using a
combination of techniques including enzyme immunoassay, direct fluorescent antibody …

The appearance of eight new respiratory viruses, including the SARS coronavirus in 2003
and swine-origin influenza A/H1N1 in 2009, in the human population in the past nine years …

Virus-infected cells secrete a broad range of interferons (IFN) which confer resistance to yet
uninfected cells by triggering the synthesis of antiviral factors. The relative contributions of …

Though several antivirals have been developed and marketed to treat influenza virus
infections, the development of antiviral agents with clinical activity against other respiratory …

Infection is the leading cause of morbidity and mortality in immunocompromised patients
such as hematopoietic/solid organ transplant recipients and individuals with human …

Respiratory viral infections are frequently associated with significant morbidity following
transplantation and are therefore of great clinical and epidemiologic interest. As new viruses …

Lung transplant recipients present an increased risk for severe complications associated
with respiratory infections. We conducted a review of the literature examining the clinical …

Both viruses and bacteria are thought to cause exacerbations of chronic obstructive
pulmonary disease (COPD); however, the relative importance of each remains uncertain. C …

Transplant physicians and surgeons are familiar with the risks, clinical behavior, and
management of cytomegalovirus in transplant recipients. Donor-transmitted viral infections …

The appearance of eight new respiratory viruses in the human population in the past 9
years, including two new pandemics (SARS coronavirus in 2003 and swine-origin influenza …